A transcriptomic signature for prostate cancer relapse prediction identified from the differentially expressed genes between TP53 mutant and wild-type tumors

For prostate cancer (PCa) patients, biochemical recurrence (BCR) is the first sign of disease relapse and the subsequent metastasis. TP53 mutations are relatively prevalent in advanced PCa forms. We aimed to utilize this knowledge to identify robust transcriptomic signatures for BCR prediction in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wensheng, Zhang, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217948/
https://www.ncbi.nlm.nih.gov/pubmed/35732666
http://dx.doi.org/10.1038/s41598-022-14436-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217948/
https://www.ncbi.nlm.nih.gov/pubmed/35732666
http://dx.doi.org/10.1038/s41598-022-14436-y

Ejemplares similares